Spruce Biosciences Inc
OTC:SPRB
Cash Flow Statement
Cash Flow Statement
Spruce Biosciences Inc
| Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||
| Net Income |
(27)
|
(30)
|
(39)
|
(40)
|
(41)
|
(42)
|
(44)
|
(44)
|
(44)
|
(46)
|
(47)
|
(48)
|
(49)
|
(48)
|
(47)
|
(43)
|
(39)
|
(53)
|
(55)
|
(48)
|
(48)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
1
|
1
|
2
|
3
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
5
|
3
|
3
|
3
|
5
|
4
|
3
|
2
|
|
| Other Non-Cash Items |
0
|
1
|
2
|
3
|
4
|
4
|
4
|
4
|
4
|
3
|
3
|
3
|
3
|
4
|
5
|
6
|
6
|
6
|
4
|
2
|
2
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
4
|
1
|
1
|
1
|
2
|
2
|
1
|
1
|
0
|
1
|
3
|
15
|
12
|
10
|
5
|
(12)
|
(13)
|
(9)
|
(3)
|
(5)
|
(1)
|
|
| Cash from Operating Activities |
(22)
N/A
|
(28)
-23%
|
(36)
-32%
|
(35)
+3%
|
(35)
0%
|
(36)
-1%
|
(39)
-8%
|
(39)
+0%
|
(40)
-3%
|
(42)
-5%
|
(42)
+0%
|
(30)
+28%
|
(34)
-12%
|
(33)
+2%
|
(36)
-10%
|
(50)
-36%
|
(46)
+6%
|
(56)
-20%
|
(54)
+4%
|
(51)
+4%
|
(48)
+8%
|
|
| Investing Cash Flow | ||||||||||||||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Items |
0
|
0
|
0
|
(61)
|
(73)
|
(79)
|
(87)
|
8
|
3
|
24
|
42
|
30
|
61
|
56
|
45
|
23
|
9
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
-40%
|
(0)
-29%
|
(61)
-67 578%
|
(73)
-20%
|
(79)
-8%
|
(87)
-9%
|
8
N/A
|
3
-59%
|
24
+654%
|
42
+76%
|
30
-28%
|
61
+102%
|
56
-9%
|
45
-19%
|
23
-49%
|
9
-60%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Financing Cash Flow | ||||||||||||||||||||||
| Net Issuance of Common Stock |
88
|
184
|
184
|
141
|
97
|
0
|
0
|
0
|
0
|
0
|
54
|
54
|
54
|
54
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
4
|
0
|
0
|
(5)
|
(5)
|
0
|
0
|
5
|
5
|
0
|
(0)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
|
| Other |
(1)
|
(3)
|
0
|
2
|
3
|
(0)
|
(0)
|
(5)
|
(5)
|
(0)
|
(3)
|
(3)
|
(3)
|
(3)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Cash from Financing Activities |
91
N/A
|
181
+98%
|
181
+0%
|
138
-24%
|
95
-31%
|
1
-99%
|
0
-58%
|
(0)
N/A
|
(0)
-1 100%
|
(0)
-100%
|
50
N/A
|
50
-1%
|
50
-1%
|
49
-1%
|
(2)
N/A
|
(2)
+4%
|
(2)
+0%
|
(2)
-5%
|
(2)
-11%
|
(2)
-2%
|
(2)
+0%
|
|
| Change in Cash | ||||||||||||||||||||||
| Net Change in Cash |
69
N/A
|
153
+123%
|
145
-6%
|
42
-71%
|
(14)
N/A
|
(114)
-730%
|
(125)
-10%
|
(31)
+75%
|
(37)
-18%
|
(18)
+50%
|
50
N/A
|
50
-1%
|
77
+54%
|
72
-7%
|
7
-90%
|
(28)
N/A
|
(39)
-39%
|
(58)
-49%
|
(56)
+4%
|
(53)
+4%
|
(49)
+7%
|
|
| Free Cash Flow | ||||||||||||||||||||||
| Free Cash Flow |
(22)
N/A
|
(28)
-23%
|
(36)
-32%
|
(35)
+3%
|
(35)
0%
|
(36)
-1%
|
(39)
-8%
|
(39)
+0%
|
(40)
-2%
|
(42)
-5%
|
(42)
+0%
|
(30)
+28%
|
(34)
-12%
|
(33)
+2%
|
(36)
-9%
|
(50)
-36%
|
(46)
+6%
|
(56)
-20%
|
(54)
+4%
|
(51)
+4%
|
(48)
+8%
|
|